ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Markets

'Suganomics' puts spotlight on potential of fertility drug makers

Japan PM's initiative to subsidize treatments helps pharmaceutical stocks surge

Prime Minister Yoshihide Suga's support for women trying to have babies could drive market growth for obstetric and gynecological drugs. (Photo by Uichiro Kasai)

TOKYO -- Stocks of midsize Japanese pharmaceutical companies have become beneficiaries of market expectations over "Suganomics," Prime Minister Yoshihide Suga's policy initiatives.

Investors started scouring the market for stocks that could ride on the momentum of the new leader's agenda even before he became prime minister.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more